Popular Articles

Westminster Kingsway College Launches New Access To Higher Education Programme In Pharmacy And Biomedical Sciences
Westminster Kingsway College has launched a new Access to Higher Education programme in Pharmacy and Biomedical Sciences at its new King"s Cross Centre in central London. The College is already a leading provider of Access to Higher Education courses in London as well as specialising in courses for Pharmacy Technicians in conjunction with the University of London"s School of Pharmacy and Birkbeck College.
new payday loan lenders
Buy zoloft and forget about depression.
Obama Presses Lawmakers On Health Reform
In President Obama"s push for health reform, "new fault lines are opening up everywhere you look. Liberals are worried that Obama is going squishy on including a strong, government-run "public option" among the health-care choices available to Americans. Conservatives are warning that the legislation won"t do enough to control health costs. Rural lawmakers are complaining that proposed Medicare cuts will fall too hard on their states," TIME reports. "And those are just the arguments going on among the Democrats. It"s all a sign that the season for hard decisions has arrived. Obama continues to project an air of confidence about the most audacious undertaking of his presidency" (Tumulty, 7/16).
News of the day
The Largest Single-site Children's Hospital In The UK Is Opening On 11th June On Manchester's Oxford Road
The development, which has taken five years to complete, is part of a ÷£500m PFI scheme, commissioned by Central Manchester University Hospitals NHS Foundation Trust (CMFT), and delivered in partnership with Catalyst Healthcare. The new Royal Manchester Children"s Hospital - a "super-hospital" for children - will be accompanied by The Manchester Royal Infirmary, Saint Mary"s Hospital and Manchester Royal Eye Hospital.
Medical Devices

Teva Announces Approval And Launch Of Tri-Lo Sprintec Tablets

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted approval for the Company"s Abbreviated New Drug Application (ANDA) to market a generic version of Ortho McNeil Janssen"s oral contraceptive, Ortho Tri-Cyclen® Lo. Shipment of this product, for which Teva"s trade name is Tri-Lo Sprintec, has commenced. As the first company to file an ANDA containing a paragraph IV certification for this product, Teva has been awarded a 180-day period of marketing exclusivity. Annual sales of Ortho Tri-Cyclen® Lo were approximately $400 million in the United States for the twelve months that ended March 31, 2009 based on IMS sales data. Teva is currently involved in patent litigation concerning this product in the U.S. District Court for the District of New Jersey. A trial date has not been set. Teva Pharmaceutical Industries Ltd.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):